Showing results (211-220 of 271) with videos related to
Sort By:
Pageof 28
Proteins|August 25, 2009
Structure prediction for CASP8 with all-atom refinement using RosettaSrivatsan Raman, Robert Vernon, James Thompson, et al.ERJ Open Research|December 2, 2021
Lower airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping reviewFlorian Gahleitner, James Thompson, Claire L Jackson, et al.BMC Medical Genomics|September 24, 2021
Whole genome sequencing in the diagnosis of primary ciliary dyskinesiaGabrielle Wheway, N Simon Thomas, Mary Carroll, et al.European Journal of Human Genetics : EJHG|November 6, 2009
Five novel loci for inherited hearing loss mapped by SNP-based homozygosity profiles in Palestinian familiesHashem Shahin, Tom Walsh, Amal Abu Rayyan, et al.Molecular Cancer Therapeutics|August 26, 2017
Radiosensitization <i>In Vivo</i> by Histone Deacetylase Inhibition with No Increase in Early Normal Tissue Radiation ToxicityBlaz Groselj, Jia-Ling Ruan, Helen Scott, et al.Cancers|August 13, 2020
Combination of Peri-Tumoral and Intra-Tumoral Radiomic Features on Bi-Parametric MRI Accurately Stratifies Prostate Cancer Risk: A Multi-Site StudyAhmad Algohary, Rakesh Shiradkar, Shivani Pahwa, et al.Genes & Development|September 17, 2014
Drosophila TRF2 is a preferential core promoter regulatorAdi Kedmi, Yonathan Zehavi, Yair Glick, et al.The Journal of Urology|August 10, 2022
Final Analysis of the Magnetic Resonance Imaging in Active Surveillance TrialPaul Doan, Matthijs J Scheltema, Amer Amin, et al.Cancer Research|October 31, 2012
A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activityLucia Guidugli, Vernon S Pankratz, Namit Singh, et al.BJUI Compass|October 3, 2025
Real-world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experienceSamantha Shekar, Megan Crumbaker, Anthony Joshua, et al.Pageof 28